MACKENZIE FINANCIAL CORP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$66,691,966
+$5,918,010 QoQ
Shares Held
86,317
+9.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $416,722,148 across 43 Biotechnology names. REGN ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,779,636 | $93,003,777 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
86,317 | $66,691,966 | |
| 3 | INCY |
Incyte Corp
|
549,633 | $51,731,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
96,709 | $43,184,436 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
441,444 | $24,937,171 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
345,683 | $23,551,382 | |
| 7 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
6,306,425 | $17,847,182 | |
| 8 | RPRX |
Royalty Pharma plc
|
170,882 | $8,197,209 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,691,966 | 86,317 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $60,773,956 | 78,736 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $72,320,854 | 128,623 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $53,244,450 | 101,418 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $42,468,040 | 66,960 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $39,200,944 | 55,032 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $58,861,030 | 55,992 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $60,921,902 | 57,964 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,793,566 | 55,890 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $49,434,552 | 56,285 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $46,370,504 | 56,346 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $42,856,599 | 59,644 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $54,813,605 | 66,710 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $51,910,484 | 71,949 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $56,305,478 | 81,736 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $52,757,170 | 89,248 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $65,588,622 | 93,910 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $55,705,116 | 88,208 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $53,600,792 | 88,570 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $49,403,421 | 88,451 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $33,199,760 | 70,169 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,813,231 | 36,872 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $17,581,010 | 31,407 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,519,819 | 23,282 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||